Syncona Portfolio LTD Achilles Therapeutics PLC Transaction History
Syncona Portfolio LTD
- $150 Million
- Q1 2024
A detailed history of Syncona Portfolio LTD transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Syncona Portfolio LTD holds 11,086,909 shares of ACHL stock, worth $9.09 Million. This represents 9.24% of its overall portfolio holdings.
Number of Shares
11,086,909
Previous 11,086,909
-0.0%
Holding current value
$9.09 Million
Previous $9.87 Million
40.45%
% of portfolio
9.24%
Previous 6.25%
Shares
1 transactions
Others Institutions Holding ACHL
# of Institutions
34Shares Held
23.5MCall Options Held
0Put Options Held
0-
Fcpm Iii Services B.V. Naarden, P72.39MShares$1.96 Million0.42% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$1.32 Million0.08% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$1.23 Million0.16% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.44MShares$1.18 Million0.24% of portfolio
-
Stem Point Capital LP New York, NY1.39MShares$1.14 Million0.46% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $33.4M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...